Johnson & Johnson (JNJ) Stock Price & Analysis

JNJ$276.32—
Drug Manufacturers - GeneralMega CapHigh Quality
Compare
Market cap$675.03BEnterprise value$692.93BRevenue (TTM)$99.33BMarket positionTop 5%

Score

38
Bearish
Value
18
Quality
69
Growth
26

AI Analysis

Snapshot

Johnson & Johnson doesn’t screen as a clean setup today — Stocklytics 38/100 leaves more to prove. Under the hood: P/E 41.9, rich vs its own history, plus revenue compounding ~6% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

18
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

26
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

69
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Johnson & Johnson (JNJ) last printed $276.32. Equity value is $675.03B. Trailing earnings multiple 42.00. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$71.89B$76.45B$81.58B$82.06B$82.58B$78.74B$79.99B$85.16B$88.82B$94.19B

About

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson (JNJ) Stock Price & Analysis

JNJ price $276.32 —

Ticker
JNJ
Price
$276.32
Change
—
Market cap
$675.03B
P/E
42.00
Forward P/E
24.93
Dividend yield
1.91%
Beta
0.23
Sector
Healthcare
Industry
Drug Manufacturers - General
Stocklytics score
38
Value
18
Quality
69
Growth
26

Stocklytics score rationale: value 18, quality 69, growth 26.

AI Score 58. The score reflects positive profitability, with a net margin of 0.162, and shareholder income through a dividend yield of 0.0193. It is moderated by a P/E ratio of 41.4203, a price-to-book ratio of 8.2016, and the absence of provided growth, estimates, and price-trend data

Summary

Johnson & Johnson operates in Healthcare within the Drug Manufacturers - General industry. The company reports a net margin of 16.2% and a dividend yield of 1.9%.

Valuation

The shares trade at a P/E ratio of 41.4 and a price-to-book ratio of 8.2. These multiples indicate a valuation that should be weighed against the company’s profitability and available growth information.

Quality

A net margin of 16.2% indicates that Johnson & Johnson retains a meaningful portion of revenue as profit. The provided facts do not include balance-sheet, cash-flow, or return-on-capital measures.

Growth

No revenue, earnings-growth, estimate-revision, or operating-growth figures are provided. Growth assessment is therefore limited by the available information.

Risks

The P/E ratio of 41.4 and price-to-book ratio of 8.2 create valuation risk if future business performance does not support those multiples. The supplied facts do not provide price-trend, estimate, or company-specific risk data.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener